Halozyme Therapeutics (HALO) Tops Q3 EPS by 5c; Offers FY23 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. NVDA
2. SPCX
3. ACN
4. MU
5. APGE
6. MSTR
7. HOOD
8. ABBV
9. DFTX
10. RGNX

Go back to Halozyme Therapeutics (HALO) Tops Q3 EPS by 5c; Offers FY23 Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 68.41 -0.14 (0.2%)
Previous Close $68.55    52 Week High $18.39 
Open $69.34    52 Week Low $6.96 
Day High $69.81    P/E N/A 
Day Low $68.41    EPS $-0.58 
Volume 125,041